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  Objective(s):  Neurotoxicity of anticancer drugs complicates treatment of cancer patients. 
Vinblastine (VBL) is reported to induce motor and cognitive impairments in patients receiving 
chronic low-dose regimen. 
Materials and Methods: The effects of VBL treatment on motor, learning and memory functions 
of male and female Wistar rats were studied by behavioral related tests. Animals were given 
chronic intraperitoneal injections of VBL (0.2 mg/kg/week for 5 weeks) from postnatal day 23 
to 52. Motor function was evaluated using grasping test and balancing was evaluated by the 
rotarod. Spatial learning and memory and anxiety-like behavior were determined using Morris 
water maze (MWM) task and open field test, respectively. 
Results: Administration of VBL caused severe damage to motor and balance function of male rats 
in comparison to female rats treated with VBL and rats treated with saline. Memory and 
locomotion were affected in both male and female rats compared with saline treated rats, while 
a sex difference was also observed in these parameters; male rats showed more impairment 
compared with female ones. Both male and female rats showed cognitive impairments in MWM 
task and no sex differences were observed in these functions. 
Conclusion: Results revealed that VBL is a potent neurotoxic agent and despite the profound 
effect of VBL on motor and cognitive functions, it seems that male rats are more susceptible to 
motor deficits induced by VBL. 
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Introduction 
Impairments in cognitive and motor functions 
are associated with chemotherapy treatment in most 
cancer survivors (1). One of the best-known classes 
of these agents is the dimeric Vinca alkaloids. Vinca 
alkaloids are one of anticancer agents in current use 
(2). Vinblastine (VBL), as an anticancer drug  from 
Vinca alkaloids family which is useful for treatment 
of malignant tumors, could penetrate in the blood-
brain barrier sufficiently so as to have a therapeutic 
effect on CNS mass lesions(3). VBL is potentially a 
useful therapeutic option in Langerhans cell 
histiocytosis with CNS mass lesions, especially for 
those with inoperable lesions or multiple lesions. In 
addition, VBL is well tolerated and can be delivered 
for a prolonged time(3). Despite therapeutic effects 
of Vinca alkaloids, some neurotoxic effects have been 
reported (4, 5). Previous data show that VBL, like the 
 
other Vinca alkaloids, binds to tubulin and induces 
an accumulation of cells in mitosis (6, 7). Compounds 
interfering with microtubule function form an 
important class of anticancer agents, widely used in 
combination chemotherapy regimens for treating 
many cancers as well as leukemias (8, 9).  
It is recognized that chemotherapy can have a 
profound toxicity for the nervous system. Long term 
studies have established that chemotherapy may 
unfavorably affect the development of higher order 
cerebral abilities and cognitive skills and also may 
impair learning and memory (10, 11).  
The Vinca alkaloids compounds, such as VBL and 
vincristine, are well-known for inducing chronic 
sensory neuropathies (12, 13), but their motor and 
cognition neurotoxicities and sex differences are less 
recognized. Therefore, the purpose of the present 
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study is to evaluate (1) whether hippocampal and 
cerebellar behavioral dysfunction occurs after 
intraperitoneal  (IP) administration of VBL, and (2) 
the relationship between sex and behavior deficits 
subsequent to chronic VBL treatment, in rats.  
To study the effect of VBL on the general health, 
the body mass and mortality rate of the animals were 
measured 23, 30, 37, 44, and 52 days after birth. 
 
Materials and Methods 
Male and primiparous female Wistar rats, 
weighing 200–250 g, were purchased from Pasture 
Institute (Tehran, Iran) and maintained in the Ani-
mal House, Kerman Neuroscience Research Center. 
Pairs of females were then placed with single 
male rats in the late afternoon. Vaginal smears or 
plugs were examined the following morning at 9:00 
AM. The day in which sperm was found, was 
designated as the gestation day of 0 (GD 0). Pups 
were weaned at 21 days of age. In the beginning of 
the experiment, animals were weight-matched and 
randomly assigned into motor and cognitive 
experimental groups with four subgroups:  Groups I 
and II consisting of male and female saline groups 
were administered normal saline (0.2 ml) 
intraperitoneally (IP) for 5 weeks; Groups III and IV 
consisted of male and female VBL groups treated 
with VBL (IP, 0.2 mg/kg for 5 weeks from postnatal 
day 23 to 52, 1 injection for each week). VBL was 
purchased from Sobhan chemotherapeutic (0.5 
mg/ml  solution,  EBEWE Pharma, Austria). Animal 
discomfort was minimized, each group consisted of a 
minimum of twelve animals (n=12). The care of 
laboratory animals followed the guiding principles 
for care and use of laboratory animals of the 
Neuroscience Research Center of Kerman Medical 
University and the study protocol was approved by 
the animal ethics committee of this institution (Code: 
EC/KNRC/91-183). Animals were kept in standard 
conditions: temperature of 22 ± 2º C and a 12-hr 
dark-light cycle. They had free access to food and 
water. We housed similarly treated female rats in the 
same cage to coordinate their sexual cycles. 
Measurements were taken during daylight (between 
8:00 and 16:00 hr). Sex-dependent motor and 
cognitive behaviors were examined 5 weeks after the 
first injection using cerebellum-dependent, motor 
learning and hippocampal functional tasks and four 
behavioral tasks, the grasping, the rotarod, the open 
field, and Morris water maze task were chosen to 
evaluate these functions. 
 
Behavioral studies 
Grasping (hanging) test 
For assessment of muscle strength and balance, 
this test was performed according to Van Wijk et al 
(2008) and Shabani et al  (2013). Each rat was 
suspended with both forepaws on a horizontal steel 
wire (80 cm long, diameter 7 mm). The animal was 
held in a vertical position when its front paws were 
placed in contact with the wire. When the rat 
grasped the wire, it was released, and the latency to 
fall was recorded with a stopwatch. Each animal was 
given three trials with a 30 min inter-trial rest 
interval (14, 15).   
  
Rotarod test 
We used the accelerating rotating rod (Hugo 
Sachs Electronik, Germany) to analyze the effects of 
VBL on motor coordination and balance skills. The 
rotarod accelerated from a minimum speed of 10 to a 
maximum speed of 60 rpm. Rats were given three 
trials using maximum time of 300 sec with a 30 min 
inter-trial rest interval. The length of time each 
animal was able to maintain its balance walking on 
top of the moving rod was recorded (16, 17). 
 
Open field test 
The open field test was used as described in 
previous studies (18). Briefly, at 52 days of age the 
horizontal and vertical activities of the male and 
female rats were recorded for a period of 5 min and 
then analyzed using Ethovision software (version 
7.1). The  apparatus consisted of a square arena 
(90×90×20 [H] cm) made of Plexiglas and its floor 
was divided by lines into 16 squares that allowed the 
definition of central and peripheral parts. At the 
beginning of the session, each rat was placed in the 
centre of the arena and its activity was recorded for 
5 min and the following behavioral parameters were 
then scored: frequency of rearing, total distance 
moved (TDM, Cm), velocity (Cm/sec), time spent in 
center and perimeter zone (sec) (19), total duration 
of mobility (sec), and immobility (s). At the end of 
each session, rats were removed from the open field 
and the experimental chamber was thoroughly 
cleaned with a damp cloth and dried (20). 
 
Morris water maze task 
The testing procedure was basically the same as 
that described by Shabani  et al  (2012). The 
experimental apparatus consisted of a circular water 
tank (140 Cm wide and 45 Cm high). A platform, 
either visible or submerged, (15 Cm wide and 35 Cm 
high) was placed 1.5 cm above or below the surface 
of the water. To assess for gross physical, sensory, 
motor, or motivational impairments, 8 rats in each 
group were first trained in a task with a visible 
escape platform. The water temperature was 21–
23°C. Data collection was automated by a video 
image motion analyzer (Ethovision, Noldus 
Information Technology, The Netherlands). In a 
single  training protocol each rat completed three 
blocks (each block consisted of four successive trials 
with four different releasing points) separated by a 
30 min resting period. All of the experimental groups 
were tested during the lights on period between 8:00 
and 12:00 hr. On each trial, rats were randomly  Parsania et al              Motor and cognitive impairments induced by VBL 
 
 Iran J Basic Med Sci, Vol. 17, No. 6, Jun 2014   
 
 
435 
 
Figure 1. Effect of Vinblastine (VBL) on muscle strength and coordination in grasping test (A) and rotarod test (B).,** P< 0.01, × P< 0.05 as 
compared with saline  and male  groups respectively. VBL did decrease muscle strength and time spent on rod compared with saline only 
in the male group. A significant difference was also observed between male and female groups. Values are expressed as mean±SEM (n=12 
for each group) 
 
released into the water from one of the four 
quadrants with their face toward the wall of the 
maze. During acquisition, the location of the platform 
remained constant and rats were allowed to swim 
for duration of 60 sec to find the hidden platform. 
After the animal found the platform, it was allowed 
to remain there for 20 – 30 sec and was then moved 
to an animal cage to wait 20 – 30 sec before the start 
of the next trial. The time and distance needed to find 
the hidden platform were collected and analyzed 
later. A single probe trial was given 2 hr after the last 
training trial to test the spatial memory in the water 
maze. In this trial the platform was removed and the 
rat was allowed to swim for 60 sec. The time and 
distance spent in the target quadrant (quadrant 4) 
were analyzed as a measure of spatial memory 
retention (21, 22).  
 
Histological study 
Under deep anesthesia, the animals were 
sacrificed and their brains removed and immersed in 
10% buffered formaldehyde at 4 ºC overnight. The 
brains were processed by the standard method for 
light microscopy study. Coronal sections 1.6–2.8 mm 
posterior to bregma were cut at a thickness of 5 µm 
using a microtome. Neuronal damage in the 
cerebellum and hippocampus were assessed by 
staining sections with  cresyl fast violet (Nissl 
staining) (23).  
 
Statistical analysis method 
The results obtained are expressed as means ± 
SEM. Two-way ANOVAs for repeated measures were 
calculated for rotarod and the learning phase of the 
Morris water maze. The grasping test, motor activity 
and probe data were analyzed by one-way ANOVA. 
Individual comparisons were calculated using 
Tukey’s comparisons test, where appropriate. Sex 
differences data were analyzed by unpaired-sample 
t-test. Data are expressed as means±SEM of twelve 
animals per group. Statistical significance was 
defined at P<0.05. All computations were made using 
the SPSS software package (version 16.0). 
Results  
Effect of VBL on muscle coordination and 
balancing 
Animals in the male VBL group showed a 
decreased latency to fall in grasping test compared to 
saline males (F(3, 38) = 9.12, P<0.01) and the female 
VBL group (F(3,  38)  = 4.65, P<0.05), but these para-
meters did not change significantly in VBL treated 
female rats compared with female saline group 
(Figure 1.A). VBL in male rats induced a significant 
reduction in time spent on accelerating rotarod 
compared with female VBL rats (F (3, 38)  = 3.91, 
P<0.05) and the saline group (F (3, 38) = 7.42, P<0.01) 
(Figure 1.B). These results indicate decreased muscle 
strength and motor balance in male VBL treated rats. 
 
Effect of VBL on explorative and anxiety related 
behaviors 
The open-field test was performed to examine 
locomotor activity and anxiety-related behavior. Our 
results showed that VBL  administration  did alter 
some of the parameters evaluated in this test and 
male rats were more susceptible to changes induced 
by VBL. The rearing number (male, F (3, 38) = 11.8, P< 
0.001; female, F (3, 38)  = 8.17, P<0.01) and total 
distance moved (male and female, F (3, 38) = 14.02, P< 
0.001) were decreased in VBL group compared with 
saline group, while animals in the female VBL group 
showed an increased rearing number and total 
distance moved compared with male VBL treated 
rats (P<0.05) (Figure 2.A, 2.B). There were no 
significant differences in the time spent in center and 
periphery (indicating no difference in anxiety related 
behavior) and speed (Figure 2.C, 2.D, and 2.E). There 
were no significant differences in duration of 
mobility (F (3, 38) = .24, P=0.17) and immobility (F (3,38) 
= .69, P=0.3) among the saline and VBL-treated 
groups (data not shown). 
 
Learning and memory alterations induced by VBL 
in Morris water maze test 
VBL increased swimming distance  (Figure 3A) 
and swimming time  (Figure 3B)  to reach the Motor and cognitive impairments induced by VBL                                                                                                      Parsania et al 
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Figure 2. Vinblastine significantly reduced rearing frequency (A) and TDM (B). Female treated rats had significant differences in rearing 
frequency and TDM with male treated rats. There were no significant differences in time spent in perimeter (C), time spent in center (D), 
and velocity (E) among the four groups. ** P< 0.01, *** P< 0.001 as compared with the control group. × P< 0.05 as compared with the male 
group 
 
platform in male and female rats in block 2 (F (3, 38) = 
9.63, P< 0.001) and block 3 (F (3, 38) = 6.19, P< 0.01) 
compared with male and female rats receiving saline 
(learning trial). Swimming speed was not different 
among the 4 groups  (Figure 3C). In the probing 
session, swimming percentage in correct quadrant (F 
(3, 38) = 3.27, P< 0.05) and swimming time percentage 
spent in correct quadrant was significantly 
decreased in male and female rats receiving VBL 
compared with saline treated rats (F (3, 38)  = 2.91, 
P<0.05)  (Figure 3D, 3E). There was no difference 
between two sexes in MWM (P> 0.05). There was no 
significant difference between the saline and VBL 
groups in crossing number in the correct quadrant 
(Figure 3F). 
 
Histological evaluation 
Light microscopy study of cerebellum and 
hippocampus sections showed normal morphology 
in the saline treated group. The Purkinje and granule 
cells in cerebellum sections and dentate gyrus, CA1, 
CA2, and CA3 of hippocampal sections in saline 
treated groups were intact. Meanwhile, severe injury 
in Purkinje cells of cerebellum sections and 
pyramidal neurons of hippocampal CA2 and CA3 
sectors in VBL-treated groups was evident (Figure 
4A, 4B). Cell population in Purkinje (Figure 4A), CA2 
and CA3 (Figure 4B) sections in the vinblastine-
treated groups showed neurodegenerative changes 
including shrunken nuclei and dark cytoplasm in 
these cells (Figure 4). 
 
Effects of adolescent exposure to VBL on mortality 
rate and body mass 
In the present study, no differences were 
observed in weight between saline and VBL groups 
on the 1st day of experimental procedure, while long-
term exposure to VBL 0.2 mg/kg (the 2nd, 3rd: P<0.01   Parsania et al              Motor and cognitive impairments induced by VBL 
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Figure 3. Hidden platform training in the Morris water maze acquisition after 5 weeks treatment with saline or vinblastine (VBL). VBL 
treated rats showed increased distance travelled (A) and time spent (B) to reach the hidden platform compared with the saline treated 
rats. There were no significant differences in swimming speed (C) and crossing numbers in the correct quadrant (F) in the probe test. In 
the probe test, the path length traveled (D) and percent swimming time (E) by VBL rats in the correct quadrant were significantly less than 
the saline groups. * P< 0.05,** P< 0.01, *** P< 0.001 as compared with the saline group 
 
Table 1. Effect of vinblastine (VBL) treatment on body weight and mortality rate of different groups of rats 
Mortality rate          Body weight (g)   
  PND  52  PND  45  PND  37  PND  30  a PND 23  Group 
1  167.8±8.1  150.1±5.8  115.5±6.1  80.7±4.2  48.2±4.01  b Saline M 
0  129±8.3  123.7±7.6  105.6±4.9  71.5±3.3  45.8±3.3  c Saline F 
3  110.2±6.5***  100.5±6.2**  75.04±6.3**  74.1±7.1  46.6±2.7  d VBL  M 
2  105.9±5.1**  97.9±4.5**  96.8±8.1  70.5±6.6  48.1±5.3  e VBL  F 
 
No differences were observed in weight between saline and VBL groups on the 1st  day of experimental procedure, while long-term 
exposure to VBL 0.2 mg/kg (the 2nd, 3rd, and 4th weeks) significantly decreased body weight in the male VBL group and in the 3rd and 4th 
weeks in female VBL rats. **, *** P< 0.01, P< 0.001, indicate statistically significant differences between male and female VBL treated rats 
compared with saline groups, respectively, (n=at least 12 rats in each group). a: Postnatal Day, b: Saline Male c: Saline Female, d: VBL Male 
and  e: VBL Female 
 
 
and 4th: P<0.001 weeks) significantly decreased body 
weight in the male VBL group and in the 3rd and 4th 
(P<0.01) weeks in female VBL rats (Table 1). 
 
Discussion 
VBL impaired motor and learning functions in 
male and female rats; yet, male rats were more 
susceptible to motor impairments induced by VBL 
compared with female rats, and these findings 
implicate a sex-dependent motor deficit observed in 
rats after chronic exposure to VBL.   
Although the toxic effects of these agents still 
remains a major limitation to their usage, vincristine 
is the most studied agent of this family and it is 
proven to have a high neurotoxic profile. The most 
important side effect of this drug is sensory loss and 
peripheral neuropathy (12), with the mechanism 
similar to colchicines; it disrupts microtubules and 
interferes with axonal and dendritic transport (5). 
Wright  et al  reported that two vinblastine deriva-
tives (S-12363 and S-12362) prevented microtubule 
assembly and differed in their ability to induce theMotor and cognitive impairments induced by VBL                                                                                                      Parsania et al 
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Figure 4. Neurons from the cerebellar cortex and hippocampus 5 weeks after exposure to Vinblastin (VBL). Most neurons from the 
cerebellum (A), and the hippocampus (B) in saline-treated rats have normal morphology (arrows), but for the VBL-treated groups, several 
degenerated cells (arrowheads) can be seen with shrinkaged nuclei and dark cytoplasm 
 
formation of tubulin paracrystals and in the stability 
of the paracrystals (24). Excitotoxic mechanisms and 
caspase-mediated cell death contribute to the 
neurotoxicity of anticancer compounds. Previous in 
vitro studies have focused on neurotoxicity of Vinca 
alkaloids in sympathetic neurons and motor neurons 
(25, 26). The excitotoxic component of anti-cancer 
drug neurotoxicity may relate to disruption of 
mitochondrial energy metabolism, resulting oxida-
tive stress, and increased vulnerability of neurons to 
physiological glutamate concentrations (27, 28). 
In this study, we have shown neurotoxic effect of 
VBL on motor and cognitive functions in male and 
female rats; as predicted, this agent could impair 
these functions. The most probable reason for this 
observation might be the same mechanism observed 
by Goldschmidt and steward (1989) for other Vinca 
alkaloids: disruption in axonal and dendritic 
transport  (29). To our knowledge, the exact 
mechanism of VBL-induced neuropathy is not clear 
yet and this subject must be addressed in further 
studies.  
Purkinje cells (PCs) play a crucial role in the 
movement control, and damages to these neurons 
would induce balance issues and movement deficits 
(16, 30). One possible mechanism for motor 
impairments observed in this study might be the 
consequent damage to PCs after chronic exposure to 
VBL, as observed in histologic evaluation. 
Male rats were more susceptible than female 
rats to the VBL-induced impairments in motor 
function. We previously have observed sex 
differences  in neurotoxic effects of anti-cancer 
agents on motor and cognitive functions (31). 
Shabani  et al  (2012) demonstrated the sex-
dependence effect of vincristine on the developing 
nervous system (4). Vincristine induced impairments 
in motor and cognitive functions of both male and 
female rats, while male rats were more susceptible to 
the toxic effect of vincristine, a finding which is 
consistent with the present study. This difference 
between male and female rats might be due to sexual 
dimorphism in brain organization and function. 
Joseph and Levine (2003) have shown the sexual 
dimorphism in PKC signaling in vincristine-induced 
peripheral neuropathy and interestingly, female rats 
showed an estrogen-dependent sexual dimorphism 
in mechanical hyperalgesia (32). 
Male rats were more susceptible to VBL-induced 
disruption in muscle strength and deficits in the 
maintenance of body balance than female rats. On 
the other hand, in female VBL-treated rats, no 
impairment was found in the grip-strength and 
motor balance tests, suggesting that muscular 
strength and motor balance in male rats is probably 
more susceptible to the effects of VBL than in female 
rats. Snell et al (2009) reported that the damage to 
vermis causes deficits in the maintenance of body 
balance, which appears as a difficulty in holding the 
head steady and the trunk erect (33). These 
impairments were seen in VBL-treated rats, which 
can be attributed to cerebellar dysfunction, probably 
derived from damage to the cerebellar vermis.   
Chemotherapeutic toxicity is affected by sex, and  Parsania et al              Motor and cognitive impairments induced by VBL 
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females are more prone to developing signs of 
toxicity (34), but in this study, male rats were more 
susceptible to the effects of VBL. We do not know the 
reason for this difference with clinical studies, but 
one possible cause might be sexual dimorphism in 
receptors and neurotransmitters affected by VBL 
(32), further research  would clarify the exact 
mechanism and help us to develop better anti-cancer 
drugs noting sexual dimorphism. Meanwhile, it is 
difficult to determine with certainty the causes of the 
observed sex differences in our study. However, it is 
suggested that these  differences may be related to 
sexual dimorphism in brain organization and func-
tion. Evidence exists for sex differences in many 
aspects of brain structure, neurotransmitter systems, 
and neuroendocrine regulation (35–37). It has been 
shown that receptor affinity of glucocorticoids in 
male rats is twice that in female rats (38). In addi-
tion, sex-dependent differences in brain develop-
ment as well as in receptor densities have been 
reported for several monoamine neurotransmitter 
systems (39). 
Cognitive function was impaired in rats receiving 
VBL, regardless of sex difference. This finding is 
consistent with our previous study showing that 
vincristine affects cognitive function of rats receiving 
chronic dosages of this anti-cancer agent (4). 
Patients receiving anti-cancer drugs show 
impairments in cognitive functions, and even some 
sex-differences have been observed in clinical 
research. Waber et al (1990) have shown cognitive 
impairments in visuoperceptual skills in patients 
treated for Acute Lymphoblastic Leukemia (ALL). 
Females were more susceptible to the 
chemotherapies and showed more severe cognitive 
impairments in comparison to males (40). Although 
we did not observe such sex-difference in cognitive 
function, the finding that cognitive processes is 
affected by anti-cancer agents is consistent with this 
study. 
Since previous studies demonstrate that Vinka 
alkaloids might not pass blood-brain barrier (BBB), 
our study shows a new evidence of CNS involvement 
in Vinka alkaloids neurotoxicity. By using histologic 
methods, we have shown that  neurons in CNS 
(cerebellum and hippocampus) are affected by VBL. 
Whether this is a direct effect of VBL or is it a result 
of VBL metabolism is a question which might be 
addressed in further research.  
In conclusion, we have shown CNS involvement 
in neurotoxicity induced by VBL and furthermore, we 
have shown that sex might play an important role in 
response to treatment with VBL, with male rats 
being more susceptible to the toxic effects of this 
anti-cancer agent. 
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